Un-promoted issues in inflammatory bowel disease: Opportunities to optimize care

Internal Medicine Journal

Volumn 40, Issue 3, 2010, Pages 173-182

  Andrews, J M ^a,b,c   Mountifield, R E ^a,c,d   Van Langenberg, D R ^a   Bampton, P A ^c,d   Holtmann, G J ^b,e  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c FLINDERS UNIVERSITY   (Australia)

^d FLINDERS MEDICAL CENTRE   (Australia)

^e UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Compliance; Fertility; Functional gastrointestinal disorder; Iron deficiency; Psychological co morbidity; Sexuality

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ANEMIA; CIGARETTE SMOKING; COMORBIDITY; CONGENITAL DISORDER; CROHN DISEASE; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG EFFICACY; EMERGENCY CARE; ENTERITIS; FAMILY PLANNING; HUMAN; IRON DEFICIENCY; MAINTENANCE THERAPY; MORBIDITY; MORTALITY; PREGNANCY; PRIORITY JOURNAL; PROCTOCOLECTOMY; PSYCHOTHERAPY; QUALITY OF LIFE; REVIEW; SEXUAL FUNCTION; SEXUALITY; SOCIAL PSYCHOLOGY; ULCERATIVE COLITIS;

COLITIS, ULCERATIVE; COMORBIDITY; CROHN DISEASE; DISEASE MANAGEMENT; HUMANS; INFLAMMATORY BOWEL DISEASES; PATIENT CARE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 77949602745     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2009.02110.x     Document Type: Review

References (92)

1. Access Economics. The Economic Costs of Crohn's Disease and Ulcerative Colitis. Access Economics 2007. Available from URL: http://www.crohnsandcolitis. com.au/content/Final-IBD-report-9-June.pdf
2. Travis SP. Review article: insurance risks for patients with ulcerative colitis or Crohn's disease. Aliment Pharmacol Ther 1997 11 : 51 9.
3. Cosnes J, Nion-Larmurier I, Beaugerie L, Afchain P, Tiret E, Gendre JP. Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery. Gut 2005 54 : 237 241.
4. Reddy SI, Friedman S, Telford JJ, Strate L, Ookubo R, Banks PA. Are patients with inflammatory bowel disease receiving optimal care? Am J Gastroenterol 2005 100 : 1357 1361.
5. Sandborn WJ, Feagan BG, Stoinov S, Honiball PJ, Rutgeerts P, Mason D et al. Certolizumab pegol for the treatment of Crohn's disease. N Engl J Med 2007 357 : 228 238.
6. Colombel JF, Sandborn WJ, Rutgeerts P, Enns R, Hanauer SB, Panaccione R et al. Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial. Gastroenterology 2007 132 : 52 65.
7. Targan SR, Hanauer SB, van Deventer SJ, Mayer L, Present DH, Braakman T et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med 1997 337 : 1029 1035.
8. Kamm MA, Sandborn WJ, Gassull M, Schreiber S, Jackowski L, Butler T et al. Once-daily, high-concentration MMX mesalamine in active ulcerative colitis. Gastroenterology 2007 132 : 66 75 quiz 432-3.
9. van den Broek FJ, Fockens P, van Eeden S, Reitsma JB, Hardwick JC, Stokkers PC et al. Endoscopic tri-modal imaging for surveillance in ulcerative colitis: randomised comparison of high-resolution endoscopy and autofluorescence imaging for neoplasia detection; and evaluation of narrow-band imaging for classification of lesions. Gut 2008 57 : 1083 1089.
10. Reese GE, Nanidis T, Borysiewicz C, Yamamoto T, Orchard T, Tekkis PP. The effect of smoking after surgery for Crohn's disease: a meta-analysis of observational studies. Int J Colorectal Dis 2008 23 : 1213 1221.
11. de Rooy EC, Toner BB, Maunder RG, Greenberg GR, Baron D, Steinhart AH et al. Concerns of patients with inflammatory bowel disease: results from a clinical population. Am J Gastroenterol 2001 96 : 1816 1821.
12. Canavan C, Abrams KR, Hawthorne B, Drossman D, Mayberry JF. Long-term prognosis in Crohn's disease: factors that affect quality of life. Aliment Pharmacol Ther 2006 23 : 377 385.
13. Drossman DA, Leserman J, Mitchell CM, Li ZM, Zagami EA, Patrick DL. Health status and health care use in persons with inflammatory bowel disease. A national sample. Dig Dis Sci 1991 36 : 1746 1755.
14. Feagan BG, Bala M, Yan S, Olson A, Hanauer S. Unemployment and disability in patients with moderately to severely active Crohn's disease. J Clin Gastroenterol 2005 39 : 390 395.
15. van Langenberg DLK, Hetzel DJ, Holtmann G, Andrews JM. Psychiatric comorbidity and prior surgery are associated with poorer patient outcomes in IBD. Australian Gastroenterology Week. October. Brisbane. J Gastroenterol Hepatol 2008 23 : A176.
16. Gibson PR, Weston AR, Shann A, Florin TH, Lawrance IC, Macrae FA et al. Relationship between disease severity, quality of life and health-care resource use in a cross-section of Australian patients with Crohn's disease. J Gastroenterol Hepatol 2007 22 : 1306 1312.
17. Blomqvist P, Ekbom A. Inflammatory bowel diseases: health care and costs in Sweden in 1994. Scand J Gastroenterol 1997 32 : 1134 1139.
18. Irvine EJ. Review article: patients' fears and unmet needs in inflammatory bowel disease. Aliment Pharmacol Ther 2004 20 (Suppl 4 54 9.
19. Sorensen VZ, Olsen BG, Binder V. Life prospects and quality of life in patients with Crohn's disease. Gut 1987 28 : 382 385.
20. Guyatt G, Mitchell A, Irvine EJ, Singer J, Williams N, Goodacre R et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology 1989 96 : 804 810.
21. Irvine EJ, Zhou Q, Thompson AK. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial. Am J Gastroenterol 1996 91 : 1571 1578.
22. Feagan BG, Sandborn WJ, Hass S, Niecko T, White J. Health-related quality of life during natalizumab maintenance therapy for Crohn's disease. Am J Gastroenterol 2007 102 : 2737 2746.
23. Casellas F, Lopez-Vivancos J, Badia X, Vilaseca J, Malagelada JR. Impact of surgery for Crohn's disease on health-related quality of life. Am J Gastroenterol 2000 95 : 177 182.
24. Lix LM, Graff LA, Walker JR, Clara I, Rawsthorne P, Rogala L et al. Longitudinal study of quality of life and psychological functioning for active, fluctuating, and inactive disease patterns in inflammatory bowel disease. Inflamm Bowel Dis 2008 14 : 1575 1584.
25. Mikocka-Walus AA, Turnbull DA, Andrews JM, Moulding NT, Wilson IG, Harley HA et al. Psychological problems in gastroenterology outpatients: a South Australian experience. Psychological co-morbidity in IBD, IBS and hepatitis C. Clin Pract Epidemol Ment Health 2008 4 : 15.
26. Mikocka-Walus A, Turnbull D, Andrews JM, Moulding N, Wilson I, Holtmann G. Psychogastroenterology: a call for psychological input in Australian gastroenterology clinics. Intern Med J 2009 39 : 127 130.
27. Graff LA, Walker JR, Lix L, Clara I, Rawsthorne P, Rogala L et al. The relationship of inflammatory bowel disease type and activity to psychological functioning and quality of life. Clin Gastroenterol Hepatol 2006 4 : 1491 1501.
28. Guthrie E, Jackson J, Shaffer J, Thompson D, Tomenson B, Creed F. Psychological disorder and severity of inflammatory bowel disease predict health-related quality of life in ulcerative colitis and Crohn's disease. Am J Gastroenterol 2002 97 : 1994 1999.
29. Andrews H, Barczak P, Allan RN. Psychiatric illness in patients with inflammatory bowel disease. Gut 1987 28 : 1600 1604.
30. Fifield J, Tennen H, Reisine S, McQuillan J. Depression and the long-term risk of pain, fatigue, and disability in patients with rheumatoid arthritis. Arthritis Rheum 1998 41 : 1851 1857.
31. Walker EA, Gelfand MD, Gelfand AN, Creed F, Katon WJ. The relationship of current psychiatric disorder to functional disability and distress in patients with inflammatory bowel disease. Gen Hosp Psychiatry 1996 18 : 220 229.
32. Mikocka-Walus AA, Turnbull DA, Moulding NT, Wilson IG, Andrews JM, Holtmann GJ. Controversies surrounding the comorbidity of depression and anxiety in inflammatory bowel disease patients: a literature review. Inflamm Bowel Dis 2007 13 : 225 234.
33. Mikocka-Walus AA, Turnbull DA, Moulding NT, Wilson IG, Andrews JM, Holtmann GJ. Antidepressants and inflammatory bowel disease: a systematic review. Clin Pract Epidemol Ment Health 2006 2 : 24.
34. Keller W, Pritsch M, Von Wietersheim J, Scheib P, Osborn W, Balck F et al. Effect of psychotherapy and relaxation on the psychosocial and somatic course of Crohn's disease: main results of the German Prospective Multicenter Psychotherapy Treatment Study on Crohn's disease. J Psychosom Res 2004 56 : 687 696.
35. Diaz Sibaja MA, Comeche Moreno MI, Mas Hesse B. [Protocolized cognitive-behavioural group therapy for inflammatory bowel disease]. Rev Esp Enferm Dig 2007 99 : 593 598.
36. Melgar S, Engstrom K, Jagervall A, Martinez V. Psychological stress reactivates dextran sulfate sodium-induced chronic colitis in mice. Stress 2008 11 : 348 362.
37. Ghia JE, Blennerhassett P, Deng Y, Verdu EF, Khan WI, Collins SM. Re-activation of inflammatory bowel disease in a mouse model of depression. Gastroenterology 2009 136 : 2280 2288.
38. Simren M, Axelsson J, Gillberg R, Abrahamsson H, Svedlund J, Bjornsson ES. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol 2002 97 : 389 396.
39. Hughes PA, Brierley SM, Martin CM, Brookes SJ, Linden DR, Blackshaw LA. Post-inflammatory colonic afferent sensitization: different subtypes, different pathways, and different time-courses. Gut 2009 58 : 1333 1341.
40. Mikocka-Walus AA, Turnbull DA, Andrews JM, Moulding NT, Holtmann GJ. The effect of functional gastrointestinal disorders on psychological comorbidity and quality of life in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2008 28 : 475 483.
41. Farrokhyar F, Marshall JK, Easterbrook B, Irvine EJ. Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: prevalence and impact on health. Inflamm Bowel Dis 2006 12 : 38 46.
42. Canani RB, Terrin G, Rapacciuolo L, Miele E, Siani MC, Puzone C et al. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease. Dig Liver Dis 2008 40 : 547 553.
43. D'Inca R, Dal Pont E, Di Leo V, Benazzato L, Martinato M, Lamboglia F et al. Can calprotectin predict relapse risk in inflammatory bowel disease? Am J Gastroenterol 2008 103 : 2007 2014.
44. Gisbert JP, Bermejo F, Perez-Calle JL, Taxonera C, Vera I, McNicholl AG et al. Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse. Inflamm Bowel Dis 2009 15 : 1190 1198.
45. Whorwell PJ, Prior A, Colgan SM. Hypnotherapy in severe irritable bowel syndrome: further experience. Gut 1987 28 : 423 425.
46. Gearry RB, Irving PM, Barrett JS, Nathan DM, Shepherd SJ, Gibson PR. Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease - a pilot study. J Crohns Colitis 2009 3 : 8 14.
47. Travis SP, Stange EF, Lemann M, Oresland T, Chowers Y, Forbes A et al. European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut 2006 55 (Suppl 1 i16 35.
48. Timmer A, McDonald JW, Macdonald JK. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev 2007 1 CD000478.
49. Sutherland L, Macdonald JK. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev 2006 2 CD000544.
50. Prefontaine E, Sutherland LR, Macdonald JK, Cepoiu M. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev 2009 1 CD000067.
51. Kane S, Huo D, Aikens J, Hanauer S. Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis. Am J Med 2003 114 : 39 43.
52. Kane SV, Cohen RD, Aikens JE, Hanauer SB. Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis. Am J Gastroenterol 2001 96 : 2929 2933.
53. Wusk B, Kullak-Ublick GA, Rammert C, von Eckardstein A, Fried M, Rentsch KM. Therapeutic drug monitoring of thiopurine drugs in patients with inflammatory bowel disease or autoimmune hepatitis. Eur J Gastroenterol Hepatol 2004 16 : 1407 1413.
54. Rutgeerts P, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF et al. Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease. Gastroenterology 2004 126 : 402 413.
55. Gupta A, Street AC, Macrae FA. Tumour necrosis factor alpha inhibitors: screening for tuberculosis infection in inflammatory bowel disease. Med J Aust 2008 188 : 168 170.
56. Desai SB, Furst DE. Problems encountered during anti-tumour necrosis factor therapy. Best Pract Res Clin Rheumatol 2006 20 : 757 790.
57. Gearry RB, Barclay ML. Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease. J Gastroenterol Hepatol 2005 20 : 1149 1157.
58. Kornbluth A, Hayes M, Feldman S, Hunt M, Fried-Boxt E, Lichtiger S et al. Do guidelines matter? Implementation of the ACG and AGA osteoporosis screening guidelines in inflammatory bowel disease (IBD) patients who meet the guidelines' criteria. Am J Gastroenterol 2006 101 : 1546 1550.
59. Somerville KW, Logan RF, Edmond M, Langman MJ. Smoking and Crohn's disease. Br Med J (Clin Res Ed) 1984 289. 954 956.
60. Parsi MA, Achkar JP, Richardson S, Katz J, Hammel JP, Lashner BA et al. Predictors of response to infliximab in patients with Crohn's disease. Gastroenterology 2002 123 : 707 713.
61. Gapasin JVLD, Hetzel DJ, Holtmann G, Andrews JM. In what proportion of IBD patients coming to resection surgery was there an opportunity to optimise preoperative care? A one year audit of a tertiary referral hospital. J Crohns Colitis 2009 3 : S79.
62. Moody GA, Mayberry JF. Perceived sexual dysfunction amongst patients with inflammatory bowel disease. Digestion 1993 54 : 256 260.
63. Timmer A, Bauer A, Dignass A, Rogler G. Sexual function in persons with inflammatory bowel disease: a survey with matched controls. Clin Gastroenterol Hepatol 2007 5 : 87 94.
64. Basson R. Sexual health of women with disabilities. CMAJ 1998 159 : 359 362.
65. Dubinsky MC. Clinical perspectives in Crohn's disease. serologic and prognostic biomarkers: who, when, and how? Rev Gastroenterol Disord 2007 7 (Suppl 2 S3 7.
66. Muller KR, Prosser R, Bamptom P, Mountifield R, Andrews JM. Female gender and surgery impair relationships, body image, and sexuality in inflammatory bowel disease: patient perceptions. Inflamm Bowel Dis 2009 Aug 27 [Epub ahead of print I, George BD, Kettlewell MG, Mortensen NJ. Impotence after mesorectal and close rectal dissection for inflammatory bowel disease. Dis Colon Rectum 2001 44 : 831 835.
67. Cornish JA, Tan E, Teare J, Teoh T, Rai R, Darzi AW et al. The effect of restorative proctocolectomy on sexual function, urinary function, fertility, pregnancy and delivery: a systematic review. Dis Colon Rectum 2007 50 : 1128 1138.
68. Rolstad SG, Moller A, Bryman I, Boman UW. Sexual functioning and partner relationships in women with Turner syndrome: some empirical data and theoretical considerations regarding sexual desire. J Sex Marital Ther 2007 33 : 231 247.
69. Waljee A, Waljee J, Morris AM, Higgins PD. Threefold increased risk of infertility: a meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis. Gut 2006 55 : 1575 1580.
70. Olsen KO, Juul S, Bulow S, Jarvinen HJ, Bakka A, Bjork J et al. Female fecundity before and after operation for familial adenomatous polyposis. Br J Surg 2003 90 : 227 231.
71. Mountifield R, Bampton P, Prosser R, Muller K, Andrews JM. Fear and fertility in inflammatory bowel disease: a mismatch of perception and reality affects family planning decisions. Inflamm Bowel Dis 2009 15 : 720 725.
72. Marri SR, Ahn C, Buchman AL. Voluntary childlessness is increased in women with inflammatory bowel disease. Inflamm Bowel Dis 2007 13 : 591 599.
73. Baird DD, Narendranathan M, Sandler RS. Increased risk of preterm birth for women with inflammatory bowel disease. Gastroenterology 1990 99 : 987 994.
74. Narendranathan M, Sandler RS, Suchindran CM, Savitz DA. Male infertility in inflammatory bowel disease. J Clin Gastroenterol 1989 11 : 403 406.
75. Burnell D, Mayberry J, Calcraft BJ, Morris JS, Rhodes J. Male fertility in Crohn's disease. Postgrad Med J 1986 62 : 269 272.
76. Mahadevan U. Fertility and pregnancy in the patient with inflammatory bowel disease. Gut 2006 55 : 1198 1206.
77. Carter JD, Ladhani A, Ricca LR, Valeriano J, Vasey FB. A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration database. J Rheumatol 2009 36 : 635 641.
78. Anderson J, Turner G, Williamson R. Fulminant colitis in late pregnancy and the puerperium. J R Soc Med 1987 80 : 492.
79. Cornish J, Tan E, Teare J, Teoh TG, Rai R, Clark SK et al. A meta-analysis on the influence of inflammatory bowel disease on pregnancy. Gut 2007 56 : 830 837.
80. Mahadevan U, Sandborn WJ, Li DK, Hakimian S, Kane S, Corley DA. Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California. Gastroenterology 2007 133 : 1106 1112.
81. Heetun ZS, Byrnes C, Neary P, O'Morain C. Review article: reproduction in the patient with inflammatory bowel disease. Aliment Pharmacol Ther 2007 26 : 513 533.
82. Ludvigsson JF, Ludvigsson J. Inflammatory bowel disease in mother or father and neonatal outcome. Acta Paediatr 2002 91 : 145 151.
83. Nielsen OH. Pregnancy in ulcerative colitis. Scand J Gastroenterol 1983 18 : 735 742.
84. Nielsen OH, Andreasson B, Bondesen S, Jacobsen O, Jarnum S. Pregnancy in Crohn's disease. Scand J Gastroenterol 1984 19 : 724 732.
85. Miller JP. Inflammatory bowel disease in pregnancy: a review. J R Soc Med 1986 79 : 221 225.
86. Dominitz JA, Young JC, Boyko EJ. Outcomes of infants born to mothers with inflammatory bowel disease: a population-based cohort study. Am J Gastroenterol 2002 97 : 641 648.
87. Orholm M, Fonager K, Sorenson H. Risk of Ulcerative colitis and Crohn's Disease among offspring of patients with chronic inflammatory bowel disease. Am J Gastroenterol 1999 94 : 3236 3238.
88. Yang H, McElree C, Roth M. Familial empirical risks for inflammatory bowel disease: differences between Jews and non Jews. Gut 1993 34 : 517 524.
89. Bennett RA, Rubin PH, Present DH. Frequency of inflammatory bowel disease in offspring of couples both presenting with inflammatory bowel disease. Gastroenterology 1991 100 : 1638 1643.
90. Gasche C, Dejaco C, Waldhoer T, Tillinger W, Reinisch W, Fueger GF et al. Intravenous iron and erythropoietin for anemia associated with Crohn disease. A randomized, controlled trial. Ann Intern Med 1997 126 : 782 787.
91. Kulnigg S, Gasche C. Systematic review: managing anaemia in Crohn's disease. Aliment Pharmacol Ther 2006 24 : 1507 1523.
92. Ahmad I, Gibson PR. Management of iron deficiency in patients admitted to hospital: time for a rethink of treatment principles. Intern Med J 2006 36 : 347 354.